SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Fuel Doctor Holdings, Inc. – ‘10-Q’ for 6/30/22 – ‘EX-101.CAL’

On:  Thursday, 8/11/22, at 5:25pm ET   ·   For:  6/30/22   ·   Accession #:  1017386-22-348   ·   File #:  0-56253

Previous ‘10-Q’:  ‘10-Q’ on 5/11/22 for 3/31/22   ·   Next:  ‘10-Q’ on 11/7/22 for 9/30/22   ·   Latest:  ‘10-Q’ on 11/13/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/11/22  Fuel Doctor Holdings, Inc.        10-Q        6/30/22   33:1.1M                                   Completion Corp./FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    285K 
 2: EX-31.1     Certification of Principal Executive Officer and    HTML     16K 
                Principal Financial Officer Pursuant to Section                  
                302 of the Sarbanes-Oxley Act of 2002.                           
 3: EX-31.2     Certification of Principal Executive Officer and    HTML     16K 
                Principal Financial Officer Pursuant to Section                  
                302 of the Sarbanes-Oxley Act of 2002.                           
 4: EX-32.1     Certification of Principal Executive Officer and    HTML     12K 
                Principal Financial Officer Pursuant to Section                  
                906 of the Sarbanes-Oxley Act of 2002                            
 5: EX-32.2     Certification of Principal Executive Officer and    HTML     12K 
                Principal Financial Officer Pursuant to Section                  
                906 of the Sarbanes-Oxley Act of 2002                            
11: R1          Cover                                               HTML     58K 
12: R2          Condensed Balance Sheets                            HTML     78K 
13: R3          Condensed Balance Sheets (Parenthetical)            HTML     30K 
14: R4          Condensed Statements of Operations                  HTML     55K 
15: R5          Condensed Statement of Stockholders Deficit         HTML     42K 
16: R6          Condensed Statements of Cash Flows                  HTML     44K 
17: R7          Note 1 - General                                    HTML     18K 
18: R8          Note 2 - Unaudited Interim Condensed Financial      HTML     18K 
                Statements                                                       
19: R9          Note 3 - Going Concern                              HTML     18K 
20: R10         Note 4 - Common Stock and Preferred Stock           HTML     23K 
21: R11         Note 5 - Related Party Transactions                 HTML     18K 
22: R12         Note 6 - Subsequent Events                          HTML     16K 
23: R13         Note 2 - Unaudited Interim Condensed Financial      HTML     19K 
                Statements (Policies)                                            
24: R14         Note 1 - General (Details Narrative)                HTML     15K 
25: R15         Note 3 - Going Concern (Details Narrative)          HTML     15K 
26: R16         Note 4 - Common Stock and Preferred Stock (Details  HTML     31K 
                Narrative)                                                       
27: R17         Note 5 - Related Party Transactions (Details        HTML     26K 
                Narrative)                                                       
28: R18         Note 6 - Subsequent Events (Details Narrative)      HTML     14K 
31: XML         IDEA XML File -- Filing Summary                      XML     47K 
29: XML         XBRL Instance -- fdoc_2022jun30-10q_htm              XML    181K 
30: EXCEL       IDEA Workbook of Financial Reports                  XLSX     34K 
 7: EX-101.CAL  XBRL Calculations -- fdoc-20220630_cal               XML     51K 
 8: EX-101.DEF  XBRL Definitions -- fdoc-20220630_def                XML     41K 
 9: EX-101.LAB  XBRL Labels -- fdoc-20220630_lab                     XML    252K 
10: EX-101.PRE  XBRL Presentations -- fdoc-20220630_pre              XML    186K 
 6: EX-101.SCH  XBRL Schema -- fdoc-20220630                         XSD     40K 
32: JSON        XBRL Instance as JSON Data -- MetaLinks              110±   145K 
33: ZIP         XBRL Zipped Folder -- 0001017386-22-000348-xbrl      Zip     71K 


‘EX-101.CAL’   —   XBRL Calculations — fdoc-20220630_cal


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" standalone="no" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
<!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://fdoc/role/Cover" xlink:href="fdoc-20220630.xsd#Cover" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/BalanceSheets" xlink:href="fdoc-20220630.xsd#BalanceSheets" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/BalanceSheetsParenthetical" xlink:href="fdoc-20220630.xsd#BalanceSheetsParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/StatementsOfOperations" xlink:href="fdoc-20220630.xsd#StatementsOfOperations" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/StatementOfStockholdersDeficit" xlink:href="fdoc-20220630.xsd#StatementOfStockholdersDeficit" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/StatementsOfCashFlows" xlink:href="fdoc-20220630.xsd#StatementsOfCashFlows" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/Note1General" xlink:href="fdoc-20220630.xsd#Note1General" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/Note2-UnauditedInterimCondensedFinancialStatements" xlink:href="fdoc-20220630.xsd#Note2-UnauditedInterimCondensedFinancialStatements" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/Note3GoingConcern" xlink:href="fdoc-20220630.xsd#Note3GoingConcern" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/Note4CommonStockAndPreferredStock" xlink:href="fdoc-20220630.xsd#Note4CommonStockAndPreferredStock" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/Note5RelatedPartyTransactions" xlink:href="fdoc-20220630.xsd#Note5RelatedPartyTransactions" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/Note6-SubsequentEvents" xlink:href="fdoc-20220630.xsd#Note6-SubsequentEvents" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/Note2-UnauditedInterimCondensedFinancialStatementsPolicies" xlink:href="fdoc-20220630.xsd#Note2-UnauditedInterimCondensedFinancialStatementsPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/Note1GeneralDetailsNarrative" xlink:href="fdoc-20220630.xsd#Note1GeneralDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/Note3GoingConcernDetailsNarrative" xlink:href="fdoc-20220630.xsd#Note3GoingConcernDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/Note4CommonStockAndPreferredStockDetailsNarrative" xlink:href="fdoc-20220630.xsd#Note4CommonStockAndPreferredStockDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/Note5RelatedPartyTransactionsDetailsNarrative" xlink:href="fdoc-20220630.xsd#Note5RelatedPartyTransactionsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://fdoc/role/Note6-SubsequentEventsDetailsNarrative" xlink:href="fdoc-20220630.xsd#Note6-SubsequentEventsDetailsNarrative" xlink:type="simple"/>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/Cover" xlink:title="00000001 - Document - Cover"/>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Balance Sheets">
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="fdoc-20220630.xsd#fdoc_AdvancedSubscriptionAgreement" xlink:label="loc_fdocAdvancedSubscriptionAgreement"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_fdocAdvancedSubscriptionAgreement" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Balance Sheets (Parenthetical)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Statements of Operations">
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="fdoc-20220630.xsd#fdoc_FinancialExpenses" xlink:label="loc_fdocFinancialExpenses"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_fdocFinancialExpenses" xlink:type="arc" weight="-1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/StatementOfStockholdersDeficit" xlink:title="00000005 - Statement - Condensed Statement of Stockholders Deficit"/>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Statements of Cash Flows">
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="fdoc-20220630.xsd#fdoc_AdvancedSubscriptionAgreementChanges" xlink:label="loc_fdocAdvancedSubscriptionAgreementChanges"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_fdocAdvancedSubscriptionAgreementChanges" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/Note1General" xlink:title="00000007 - Disclosure - NOTE 1 &#8211; GENERAL"/>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/Note2-UnauditedInterimCondensedFinancialStatements" xlink:title="00000008 - Disclosure - NOTE 2 - UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/Note3GoingConcern" xlink:title="00000009 - Disclosure - NOTE 3 &#8211; GOING CONCERN"/>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/Note4CommonStockAndPreferredStock" xlink:title="00000010 - Disclosure - NOTE 4 &#8211; COMMON STOCK AND PREFERRED STOCK"/>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/Note5RelatedPartyTransactions" xlink:title="00000011 - Disclosure - NOTE 5 &#8211; RELATED PARTY TRANSACTIONS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/Note6-SubsequentEvents" xlink:title="00000012 - Disclosure - NOTE 6 - SUBSEQUENT EVENTS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/Note2-UnauditedInterimCondensedFinancialStatementsPolicies" xlink:title="00000013 - Disclosure - NOTE 2 - UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS (Policies)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/Note1GeneralDetailsNarrative" xlink:title="00000014 - Disclosure - NOTE 1 &#8211; GENERAL (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/Note3GoingConcernDetailsNarrative" xlink:title="00000015 - Disclosure - NOTE 3 &#8211; GOING CONCERN (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/Note4CommonStockAndPreferredStockDetailsNarrative" xlink:title="00000016 - Disclosure - NOTE 4 &#8211; COMMON STOCK AND PREFERRED STOCK (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/Note5RelatedPartyTransactionsDetailsNarrative" xlink:title="00000017 - Disclosure - NOTE 5 &#8211; RELATED PARTY TRANSACTIONS (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://fdoc/role/Note6-SubsequentEventsDetailsNarrative" xlink:title="00000018 - Disclosure - NOTE 6 - SUBSEQUENT EVENTS (Details Narrative)"/>
</link:linkbase>

Top
Filing Submission 0001017386-22-000348   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 7:34:03.1am ET